Variation in the Calpain-10 gene is not associated with gestational diabetes mellitus

References

• Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wie S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163–75.
   PubMed Web of Science ®Google Scholar
• Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, Silander K, Valle TT, Buchanan TA, Tuomilehto J, Bergman RN, Boehnke M, Collins FS. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 2002;51: 1644–8.
   PubMedGoogle Scholar
• Hegele RA, Harris SB, Zinman B, Hanley AJ, Cao H. Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 2001; 24:1498–9.
   Web of Science ®Google Scholar
• Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, Hanis CL, Hasstedt SJ. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002;87:650–4.
   PubMedGoogle Scholar
• Takeuchi M, Okamoto K, Takagi T, Ishii H. Ethnic difference in patients with type 2 diabetes mellitus in inter-East Asian populations: a systematic review and meta-analysis focusing on gene polymorphism. J Diabetes 2009;1:255–62.
   Google Scholar
• Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST, Tufa J, Viali S, Deka R. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 2001;69:1236–44.
   PubMedGoogle Scholar
• Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM, Horikawa Y, Cox NJ, Bell GI, Walker M. Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 2002;51:247–50.
   PubMedGoogle Scholar
• Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, Levy JC, O’Rahilly S, Rao PV, Bennett AJ, Jones EC, Menzel S, Prestwich P, Simecek N, Wishart M, Dhillon R, Fletcher C, Millward A, Demaine A, Wilkin T, Horikawa Y, Cox NJ, Bell GI, Ellard S, McCarthy MI, Hattersley AT. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001;69:544–52.
   PubMedGoogle Scholar
• Orho-Melander M, Klannemark M, Svensson MK, Ridderstrale M, Lindgren CM, Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 2002;51:2658–64.
   Google Scholar
• Demirci M, Yurtcu E, Ergun MA, Yazici AC, Karasu C, Yetkin I. Calpain 10 gene SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions. Genet Test 2008;12:305–9.
   Google Scholar
• Alsaraj F, O’Gorman D, McAteer D, McDermott J, Hawl Z, Sreenan S. Haplotype association of calpain 10 gene variants with type 2 diabetes mellitus in an Irish sample. Ir J Med Sci 2010;179:269–72.
   Google Scholar
• Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J, Sieradzki J. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 2002;146:695–9.
   Google Scholar
• Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL, Boerwinkle E, Shuldiner AR. SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 2002; 51:231–7.
   Google Scholar
• Tsuchiya T, Schwarz PE, Bosque-Plata LD, Geoffrey Hayes M, Dina C, Froguel P, Towers GW, Fischer S, Temelkova- Kurktschiev T, Rietzsch H, Graessler J, Vcelak J, Palyzova D, Selisko T, Bendlova B, Schulze J, Julius U, Hanefeld M, Weedon MN, Evans JC, Frayling TM, Hattersley AT, Orho-Melander M, Groop L, Malecki MT, Hansen T, Pedersen O, Fingerlin TE, Boehnke M, Hanis CL, Cox NJ, Bell GI. Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab 2006;89:174–84.
   PubMedGoogle Scholar
• Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen RQ, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus CA. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000;106:R69–73.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Taylor KD, Guo X, Quinones MJ, Cui J, Li Y, Saad MF, Yang H, Hsueh WA, Hodis HN, Rotter JI. Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study. Diabetes 2005;54:1228–32.
   Google Scholar
• Goodarzi MO, Taylor KD, Jones MR, Fang B, Guo X, Xiang AH, Buchanan TA, Hodis HN, Raffel LJ, Rotter JI. Replication of calpain-10 genetic association with carotid intima-media thickness. Atherosclerosis 2009;205:503–5.
   Google Scholar
• Carlsson E, Fredriksson J, Groop L, Ridderstrale M. Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J Clin Endocrinol Metab 2004;89:3601–5.
   PubMedGoogle Scholar
• Gonzalez A, Abril E, Roca A, Aragon MJ, Figueroa MJ, Velarde P, Royo JL, Real LM, Ruiz A. CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:3971–6.
   PubMedGoogle Scholar
• Yilmaz M, Yurtcu E, Demirci M, Ergün MA, Ersoy R, Karakoc A, Yetkin I, Cakir N, Ayvaz G, Arslan M. Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome. J Endocrinol Invest 2009;32:13–7.
   PubMed Web of Science ®Google Scholar
• Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2004;2:13–27.
   PubMedGoogle Scholar
• Linné Y, Barkeling B, Rössner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002;109:1227–31.
   PubMed Web of Science ®Google Scholar
• Noussitou P, Monbaron D, Vial Y, Gaillard RC, Ruiz J. Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland. Diabetes Metab 2005;31(4 Pt1):361–9.
   Google Scholar
• Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, Chatzianagnostou K, Bottone P, Teti G, Del Prato S, Benzi L. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Re Clin Pract 2003;62:131–7.
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Bancher-Todesca D. Gestational diabetes. Wien Med Wochenschr 2003;153:478–84.
   Google Scholar
• Ward WK, Johnston CL, Beard JC, Benedetti TJ, Halter JB, Porte D Jr. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 1985;34:861–9.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903–16.
   PubMed Web of Science ®Google Scholar
• Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999;48:1807–14.
   PubMed Web of Science ®Google Scholar
• Weijers RN, Bekedam DJ. Relationship between gestational diabetes mellitus and type 2 diabetes: evidence of mitochondrial dysfunction. Clin Chem 2007;53:377–83.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Coustan DR. Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes mellitus. Diabet Care 1998;21(Suppl. 2):B11–167.
   Google Scholar
• Abraham BK, Justenhoven C, Pesch B, Harth V, Weirich G, Baisch C, Rabstein S, Ko YD, Brüning T, Fischer HP, Haas S, Brod S, Oberkanins C, Hamann U, Brauch H;GENICA Network: Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1102–7.
   Google Scholar
• Ortiz-Pallardo ME, Zhou H, Fischer HP, Neuhaus T, Sachinidis A, Vetter H, Brüning T, Ko Y. Rapid analysis of alpha1-antitrypsin PiZ genotype by a real-time PCR approach. J Mol Med 2000;78:212–6.
   PubMed Web of Science ®Google Scholar
• Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004;27:21–32.
   Google Scholar
• Becker T, Cichon S, Jönsen E, Knapp M. Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet 2005;69(Pt 6):747–56.
   Google Scholar
• Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, Ramachandran A, Snehalatha C, Gelding SV, Vijayaravaghan S, Curtis D, Hitman GA. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 2002;51:1622–8.
   Google Scholar
• Sáez ME, González-Sánchez JL, Ramírez-Lorca R, Martínez-Larrad MT, Zabena C, González A, Morón FJ, Ruiz A, Serrano-Ríos M. The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population. PloS One 2008;3:e2953.
   Google Scholar
• Leipold H, Knöfler M, Gruber C, Haslinger P, Bancher-Todesca D, Worda C. Calpain-10 haplotype combination and association with gestational diabetes mellitus. Obstet Gynecol 2004;103:1235–40.
   PubMed Web of Science ®Google Scholar
• Wu HR, Yang HX. Association of the calpain-10 gene polymorphism with glucose metabolism disorder in pregnant women. Zhonghua Fu Chan Ke Za Zhi 2009;44:183–7.
   PubMedGoogle Scholar
• Luo YP, Xue YM, Zhao YQ. [Single-nucleotide polymorphisms and genotype combinations in calpain-10 gene of gestational diabetes mellitus.]. Zhonghua Liu Xing Bing Xue Za Zhi 2009;30:101–2.
   PubMedGoogle Scholar
• Kifagi C, Makni K, Mnif F, Boudawara M, Hamza N, Rekik N, Abid M, Rebaï A, Granier C, Jarraya F, Ayadi H. Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes Metab 2008;34: 273–8.
   Google Scholar
• Hauner H, Hanisch J, Bramlage P, Steinhagen-Thiessen E, Schunkert H, Jöckel KH, Wasern J, Moebus S. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metablic and Cardiovascular Risk Project (GEMCAS). Exp Clin Endocrinol Diabetes 2008;116:18–25.
   Google Scholar
• Meisinger C, Strassburger K, Heier M, Thorand B, Baumeister SE, Giani G, Rathmann W. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35–59 year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med 2010;27:360–2.
   Google Scholar
• Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485–91.
   PubMed Web of Science ®Google Scholar
• Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI. Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 2004;53(Suppl. 1):S19–25.
   Google Scholar